J&J suspends COVID-19 vaccine sales forecast
The vaccine brought in $2.38 billion in sales last year
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Johnson & Johnson
US FDA approves cancer therapy by Johnson & Johnson and Legend Biotech
The treatment, Carvykti/Cilta-cel, belongs to a class of drugs known as CAR-T therapies, or chimeric antigen receptor T-cell…
J&J reaches opioid settlement with holdout state New Mexico
Under the accord, J&J agreed to pay New Mexico its share of the nationwide settlement in 2022, rather than over several years,…
J&J says single dose protects against breakthrough COVID-19 for up to six months
The study, sponsored by the vaccine developer, was conducted between 1st January and 7th September last year, before the Omicron…
Vaccine makers could make Omicron-specific booster, says Fauci
The US government is working with Moderna, Pfizer and J&J on multiple contingency plans, infectious disease expert Anthony…
Schneider Electric launches programme to increase access to renewable energy for pharmaceutical…
The collaboration aims to accelerate the adoption of renewable energy and reduce greenhouse gas emissions within the…
FDA takes additional actions on use of booster dose for COVID-19 vaccines
The US health regulator talks about using single booster dose of the vaccines developed by Moderna, Johnson & Johnson and…
Aspen in talks with Johnson & Johnson to produce and market COVID-19 vaccine
The company is also looking to expand its COVID-19 vaccine manufacturing under a contract with J&J, from 300 million doses to…
Johnson & Johnson’s HIV vaccine fails mid-stage study in Africa
The mid-stage trial failure highlights the challenges of vaccine development, especially for HIV or human immunodeficiency virus,…
Booster dose ups antibodies, says J&J
A second dose of the J&J single-dose vaccine resulted in binding antibody levels nine times higher than the levels 28 days…